Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Responses to Influenza Vaccination in Healthy Adults
NCT05108818Phase 4Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Oct 2021
- Primary completion
- Apr 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of ARCT-2138 in influenza, sponsored by University of Pennsylvania. Started Oct 2021; status: recruiting.
02
Drugs
ARCT-2138
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05108818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05108818.